Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03603730 · ClinicalTrials.gov registry record · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
A NA study of Gastroparesis and Dyspepsia, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT03603730 is a NA study of Gastroparesis and Dyspepsia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 65 participants, below the 301-participant average among 44 other Gastroparesis trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03603730, a NA study of Gastroparesis and Dyspepsia, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
Explore the effects of auricular transcutaneous vagal nerve stimulation (taVNS) on brain and stomach outcomes in functional dyspepsia and gastroparesis patients.
Conditions Studied
Interventions
- DEVICE taVNS
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2018-11-30 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03603730
The ClinicalTrials.gov registry entry for NCT03603730 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 44 other Gastroparesis trials with a reported enrollment target (78% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which taVNS is the first listed.
NCT03603730 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03603730 about?
NCT03603730 is a clinical study titled "Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis". Explore the effects of auricular transcutaneous vagal nerve stimulation (taVNS) on brain and stomach outcomes in functional dyspepsia and gastroparesis patients.
What is the current status of trial NCT03603730?
This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2018-11-30. Estimated completion is 2028-03-31.
What conditions does trial NCT03603730 study?
This clinical trial studies the following conditions: Gastroparesis, Dyspepsia.
What interventions are being tested in trial NCT03603730?
The interventions under investigation include: taVNS (DEVICE).
Who is sponsoring clinical trial NCT03603730?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03603730 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
-
Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis
RECRUITING · NA
-
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
RECRUITING · NA
-
Study of Enterra Programming with Nocturnal Cycling in Gastroparetics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.